By Anuja Vaidya
Here are 150 insights and notes on the second quarter financial reports of some of the most prominent orthopedic and spine device companies.
Medtronic
(First quarter of 2015)
1. Medtronic reported $7.2 billion worldwide revenue for the quarter, a 12 percent increase including an extra week benefit. However, foreign currency translation had a negative $529 million impact on revenue.
2. Revenue in the United States reached $4.1 billion, up 14 percent. United States revenue represented 57 percent of the company’s entire revenue. The non-U.S. developed market revenue was up 10 percent to $2.1 billion.
